Chronic Limb-Threatening Ischemia clinical trials at UCSD
1 research study open to eligible people
Showing trials for
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
open to eligible people ages 18-95
A prospective, single-arm, multi-center study designed to gather additional information on the LimFlow System.
La Jolla, California and other locations
Our lead scientists for Chronic Limb-Threatening Ischemia research studies include Ann Gaffey.
Last updated: